Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohort.
Cescon AM, Cooper C, Chan K, Palmer AK, Klein MB, Machouf N, Loutfy MR, Raboud J, Rachlis A, Ding E, Lima VD, Montaner JS, Rourke SB, Smieja M, Tsoukas C, Hogg RS; CANOC Collaboration. Cescon AM, et al. HIV Med. 2011 Jul;12(6):352-60. doi: 10.1111/j.1468-1293.2010.00890.x. Epub 2010 Nov 8. HIV Med. 2011. PMID: 21059167 Free article.
Impact of the Data Collection on Adverse Events of Anti-HIV Drugs cohort study on abacavir prescription among treatment-naive, HIV-infected patients in Canada.
Antoniou T, Gillis J, Loutfy MR, Cooper C, Hogg RS, Klein MB, Machouf N, Montaner JS, Rourke SB, Tsoukas C, Raboud JM; Canadian Observational Cohort (CANOC) collaboration. Antoniou T, et al. J Int Assoc Provid AIDS Care. 2014 Mar-Apr;13(2):153-9. doi: 10.1177/2325957413495565. Epub 2013 Jul 25. J Int Assoc Provid AIDS Care. 2014. PMID: 23887923 Free article.
Factors associated with late initiation of highly active antiretroviral therapy among young HIV-positive men and women aged 18 to 29 years in Canada.
Palmer AK, Cescon A, Chan K, Cooper C, Raboud JM, Miller CL, Burchell AN, Klein MB, Machouf N, Montaner JS, Tsoukas C, Hogg RS, Loutfy MR; CANOC Collaboration. Palmer AK, et al. J Int Assoc Provid AIDS Care. 2014 Jan-Feb;13(1):56-62. doi: 10.1177/2325957413510606. Epub 2013 Dec 5. J Int Assoc Provid AIDS Care. 2014. PMID: 24309754 Free article.
Gender differences in clinical outcomes among HIV-positive individuals on antiretroviral therapy in Canada: a multisite cohort study.
Cescon A, Patterson S, Chan K, Palmer AK, Margolese S, Burchell AN, Cooper C, Klein MB, Machouf N, Montaner JS, Tsoukas C, Hogg RS, Raboud JM, Loutfy MR; CANOC Collaboration. Cescon A, et al. PLoS One. 2013 Dec 31;8(12):e83649. doi: 10.1371/journal.pone.0083649. eCollection 2013. PLoS One. 2013. PMID: 24391803 Free PMC article. Clinical Trial.
Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in Canada.
Samji H, Taha TE, Moore D, Burchell AN, Cescon A, Cooper C, Raboud JM, Klein MB, Loutfy MR, Machouf N, Tsoukas CM, Montaner JS, Hogg RS; Canadian Observational Cohort (CANOC) Collaboration. Samji H, et al. Among authors: tsoukas cm. HIV Med. 2015 Feb;16(2):76-87. doi: 10.1111/hiv.12173. Epub 2014 Sep 1. HIV Med. 2015. PMID: 25174373 Free PMC article.
A comparison of virological suppression and rebound between Indigenous and non-Indigenous persons initiating combination antiretroviral therapy in a multisite cohort of individuals living with HIV in Canada.
Benoit AC, Younger J, Beaver K, Jackson R, Loutfy M, Masching R, Nobis T, Nowgesic E, O'Brien-Teengs D, Whitebird W, Zoccole A, Hull M, Jaworsky D, Rachlis A, Rourke S, Burchell AN, Cooper C, Hogg R, Klein MB, Machouf N, Montaner J, Tsoukas C, Raboud J; Building Bridges; Canadian Observational Cohort Collaboration. Benoit AC, et al. Antivir Ther. 2017;22(4):325-335. doi: 10.3851/IMP3114. Epub 2016 Dec 7. Antivir Ther. 2017. PMID: 27925609
91 results